The doubling of the equity incentive pool signals management intends to continue issuing large equity grants, likely sustaining the $9.5M annual share-based compensation run rate that drove the FY 2025 net loss. With only $700K cash and negative operating cash flow, further dilution is the primary source of 'compensation' — watch the next 20-F for the actual number of shares granted and the resulting compensation expense.
Price Chart
Executive Summary
JX Luxventure Group is doubling the share reserve under its 2026 Equity Incentive Plan from 4.5M to 9.3M shares, approved by the board and holders of ~63% of voting stock. This massive potential dilution (4.8M new shares) comes on top of a deeply distressed balance sheet — $700K cash, $82.3M accumulated deficit, and a material weakness in internal controls — and follows a year where $9.5M in share-based compensation already drove a $11.0M net loss.
Key Facts
- Share reserve under the 2026 Equity Incentive Plan increased from 4,500,000 to 9,300,000 shares — a 4,800,000 share increase.
- Approved by board unanimous consent and holders of ~63% of outstanding voting capital (7,554,888 common shares plus all Series A, C and D Convertible Preferred on as-converted basis).
- Filing follows FY 2025 annual report showing $11.0M net loss, $9.5M share-based compensation, $700K cash on hand, $82.3M accumulated deficit, and a material weakness in internal controls.
- The 2026 Plan was originally adopted on January 5, 2026 — this amendment comes less than 9 months later.
Financial Impact
Potential dilution of up to 4.8M new shares (more than doubling the plan's share pool) on a company with only $700K cash and a history of heavy share-based compensation; no cash infusion to the company from equity incentive grants.
Risk Factors
- Massive potential dilution — 4.8M new shares authorized for issuance, which could increase the fully diluted share count substantially.
- Continued share-based compensation at prior levels ($9.5M in FY 2025) would sustain or deepen net losses given the company's negative operating cash flow.
- Material weakness in internal controls (disclosed in FY 2025 20-F) raises governance concerns around equity grant processes.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-102000 |
| Document: ea030617701ex10-1.htm | 0001213900-26-102000 |
| Document: 0001213900-26-102000-index-headers.html | 0001213900-26-102000 |
| Document: 0001213900-26-102000-index.html | 0001213900-26-102000 |
| Document: 0001213900-26-102000.txt | 0001213900-26-102000 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | SC 13D/A | $7.76 $6.98 | ▼ −10.05% | ▼ −9.91% | $6.91 (−10.95%) |
Oct 19, 2026 8d ago | SC 13D/A | $7.76 $6.98 | ▼ −10.05% | ▼ −9.91% | $6.91 (−10.95%) |
Sep 22, 2026 5w ago | 6-K | $6.63 $7.25 | ▼ −9.35% | ▼ −10.54% | $6.91 (−4.22%) |
May 22, 2026 22w ago | 6-K | $6.91 $8.51 | ▼ −23.15% | ▼ −22.07% | $6.91 (+0.00%) |
May 15, 2026 23w ago | 6-K | $6.53 $7.23 | ▲ +10.72% | ▲ +9.76% | $6.91 (+5.82%) |
May 15, 2026 23w ago | 20-F | $6.53 $7.23 | ▼ −10.72% | ▼ −9.76% | $6.91 (−5.82%) |
Apr 14, 2026 28w ago | 6-K | $4.01 $3.96 | ▲ +1.25% | ▲ +2.64% | $6.91 (−72.32%) |
Apr 10, 2026 28w ago | 6-K | $3.95 $4.11 | ▲ +4.05% | ▲ +0.76% | $6.91 (+74.94%) |
Mar 26, 2026 30w ago | 6-K | $3.78 $3.73 | ▲ +1.32% | ▲ +2.96% | $6.91 (−82.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers